Gingival Overgrowth Flashcards
causes of gingival overgrowth
medication side effects
inherited - fibromatosis
idiopathic (no one knows why)
Phenytoin
drug that causes side effect of gingival overgrowth characterized by increase in FIBROTIC/HARD TISSUE GROWTH
Nifedipine
drug that can cause gingival overgrowth characterized by a mixture of increased fibrottic tissue and inflammation
Cyclosporin A
drug that can have a side effect of causing gingival overgrowth and most commonly causes inflammation
given to treat immunosuppresent individuals so inhibits the acquired immune response –> so the innate becomes exxagerated
Phenytoin, Nifedipine, and Cyclosporin A are all?
drugs that can cause the side effects of gingival overgrowth
Features of gingival overgrowth
- varying degrees of inflammation and fibrosis
- THICKENED EPITHELIUM -> no matter the kind of gingival overgrowth this will be seen
- thickened connective tissue
can all have negative effects on oral hygeine, more bacteria has spaces and spots to attack and can cause systemic problems potentially?
two types of gingival overgrowth and their characteristics
fibrotic overgrowth and inflammatory overgrowth
what will thickened epithelium show histologically?
RETE PEGS INCREASE IN ALL TYPES - spikes or pegs from epithelium going into the connective tissue
also…there will ALWAYS be some level of inflammation (just depends on amount that is determining factor)
what area of gingiva may have the most inflammation?
sulcular epithelium
CTGF (CNN2)
molecular marker (grwoth factor) that is upregulated in FIBROTIC gingival overgrowth - so elevated in phenytoin and Nifedipine induced gingival overgrwoth
upregulated by TGF-beta
matricellular protein
strongly promotes fibrosis
BUT IS DOWN REGULATED IN NON ORAL CELLS LIKE LUNG AND KIDNEY
CCN2 in non oral cells
DOWNREGULATED and basically shut off by inflammatory mediators like TNF-alpha and PGE2
like in lung and kidney cells
WHEN THERE IS INFLAMMATION PRESENT IN NON ORAL TISSUES CCN2 IS SHUT OFF BY THESE
TNF-alpha and PGE2
down regulate inflammation like CCN2 in tissues in cells NOT IN THE ORAL CAVITY –> PGE2 does not block the expression of CNN2 in the oral cavity
but when have gingival inflammtion and majorly fibrotic overgrowth due to PHE - the CNN2 resists the down regulation of the PGE and TNF-alpha - supporting that there is different fibroblasts in the oral cavity than in other places like the lung and kidney
receptor for PGE2
EP3 –> stimulate the JNK pathway to increase the CTFG expression –> more tgf-beta and cnn2
EP2/4 –> inhibitory of the JNK and thus reduced CTFG expression through adenylate cyclase –> cAMP–> PKA–> inhibit the JNK
ERK, p38
receptors for TGF-beta? – increase the CTGF expression
Lovastatin
inhibitor of HMG-CoA reductase which will inhibit the biosynthetic pathway of cholestroel and thus reduce production of FA that are incorporated onto Ras and Rho that can contribute to the expression of CTGF through the activation of Rac1/cdc42